Search results
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoCRISPR Therapeutics AG (CRSP) possesses the right combination of the two key ingredients for a...
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 2.61% and 97.33%,...
CRISPR Therapeutics AG (CRSP) Reports Q3 2023 Financial Results, Highlights Progress in ...
GuruFocus.com via Yahoo Finance· 7 months agoCRISPR Therapeutics AG (NASDAQ:CRSP) reported a net loss of $112.2 million for Q3 2023, a...
CRISPR Therapeutics AG (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 9 months agoA month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have...
CRISPR Therapeutics AG (CRSP) Stock Moves -0.1%: What You Should Know
Zacks via Yahoo Finance· 5 months agoCRISPR Therapeutics AG (CRSP) closed the most recent trading day at $62.63, moving -0.1% from the...
What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) closed at $55.27 in the latest trading session, marking a -1.51% move...